Is the “3 by 5” Initiative the Best Approach to Tackling the HIV Pandemic?
暂无分享,去创建一个
[1] China Tuberculosis Control Collaboration. The effect of tuberculosis control in China , 2004, The Lancet.
[2] J. Stephenson. Report: HIV prevention efforts remain crucial as global treatment access expands. , 2004, Journal of the American Medical Association (JAMA).
[3] T. Edejer,et al. Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? , 2004, The Lancet.
[4] J. Zarocostas. WHO puts HIV/AIDS pandemic at top of its agenda , 2004, The Lancet.
[5] Thomas R Frieden,et al. Controlling tuberculosis in India. , 2002, The New England journal of medicine.
[6] J. Sachs. Macroeconomics and health: investing in health for economic development , 2002 .
[7] Elizabeth Marum,et al. Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century , 2002, The Lancet.
[8] J. Fisher,et al. First, do no harm: a call for emphasizing adherence and HIV prevention interventions in active antiretroviral therapy programs in the developing world. , 2002, AIDS.
[9] Dorothy Bray,et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.
[10] R. Bayer. Public health policy and the AIDS epidemic. An end to HIV exceptionalism? , 1991, The New England journal of medicine.
[11] N. Michael,et al. Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.
[12] Shenglan Tang,et al. The effect of tuberculosis control in China. Comment , 2004 .
[13] Ilo Programme on Hiv. HIV/AIDS and work : global estimates, impact and response , 2004 .
[14] R. Feachem. Commission on Macroeconomics and Health. , 2002, Bulletin of the World Health Organization.